KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Cash from Investing Activities (2016 - 2025)

BeOne Medicines (ONC) has disclosed Cash from Investing Activities for 11 consecutive years, with -$38.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 59.05% to -$38.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$276.2 million, a 49.64% increase, with the full-year FY2025 number at -$276.2 million, up 49.64% from a year prior.
  • Cash from Investing Activities was -$38.3 million for Q4 2025 at BeOne Medicines, up from -$49.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $658.7 million in Q2 2022 to a low of -$209.8 million in Q1 2024.
  • A 5-year average of $41.1 million and a median of -$29.8 million in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: soared 1512.96% in 2022, then crashed 263.76% in 2024.
  • BeOne Medicines' Cash from Investing Activities stood at -$21.2 million in 2021, then soared by 281.68% to $38.5 million in 2022, then tumbled by 262.4% to -$62.6 million in 2023, then tumbled by 49.57% to -$93.6 million in 2024, then surged by 59.05% to -$38.3 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Cash from Investing Activities are -$38.3 million (Q4 2025), -$49.3 million (Q3 2025), and -$66.6 million (Q2 2025).